CDKN2A and hepatocellular carcinoma: Since low-levels of methylation were also detected in the background non-cancerous liver of the HCC patients, we normalized methylation levels in HCC tissues to the background aberrant methylation and determined that p16INK4a methylation inactivates the gene in 63% of human HCC cases (Fig. 1) [28].